Marcan Pharmaceuticals Recalls Blood Pressure Drug
Analysis based on 7 articles · First reported Feb 08, 2026 · Last updated Feb 10, 2026
The recall of MAR-Amlodipine 5 mg tablets by Marcan Pharmaceuticals due to a medication mix-up could negatively impact consumer trust in pharmaceutical products and potentially lead to increased scrutiny from regulatory bodies like Canada — Health Canada. For Marcan Pharmaceuticals, this event is likely to result in financial costs associated with the recall, potential lawsuits, and damage to its brand reputation.
Marcan Pharmaceuticals has initiated a nationwide recall of two lots of its MAR-Amlodipine 5 mg tablets, a medication for high blood pressure and chest pain. The recall was prompted by the inadvertent packaging of midodrine 2.5 mg tablets, used to treat low blood pressure, into bottles labeled as MAR-Amlodipine. Canada — Health Canada issued a public advisory, warning of serious health risks, including dangerously high blood pressure and organ damage, if patients mistakenly take midodrine instead of amlodipine. Consumers in Canada are advised to check their medication bottles for round tablets, which indicate the incorrect drug, and return them to pharmacies. Canada — Health Canada is monitoring the recall and investigation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard